Sands BE, Panaccione R, D'Haens G, Schreiber S, et al. Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial. Lancet Gastroenterol Hepatol 2025 Jan 7:S2468-1253(24)00386.
PMID: 39793589